Cubbie has enlisted Internet of Things (IoT) solutions provider Wireless Logic to connect new and existing Cubbie hubs installed across locations, including schools and hospitals, via its Conexa Network.
Founded in 2013, the Irish company’s Cubbie hubs are multi-sensory spaces for individuals with conditions, including autism and ADHD. The hubs are designed to help patients manage symptoms or for those with sensory processing difficulties and social-behavioural well-being needs.
Go deeper with GlobalData
According to research by Cubbie, the hubs, around 200 of which are currently installed at sites across the UK and Ireland, can reduce anxiety and encourage participation in less than 15 minutes.
Connectivity supported by Wireless Logic’s network will enable hub users to access personalised programmes tailored to each individual’s sensory profile through the hubs’ cloud-based software at any location in which a hub is installed.
Currently prioritising sites experiencing the most inconsistent connectivity for the switch to Conexa, Cubbie stated that the network is already improving connectivity uptime for the hubs, and the plan over time is for the network to eventually support streamlined manufacturing, distribution processes, and advanced data analytics.
Cubbie inventor and founder David McIntyre commented: “Sound, light and other sensory inputs can be overwhelming for people with sensory processing difficulties; they can even cause pain.
“Cubbie’s software-driven technology links schools and other sites with sensory integration experts so children and adults with neurodivergence, sensory stress or anxiety can positively engage in education and other daily activities, rather than being excluded.”
Elsewhere in the field of neurodivergence, AI-based startup Paloma Health raised £2m ($2.52m) in pre-seed funding last year, which it plans to use to deliver faster, UK National Health Service (NHS)-backed autism assessments for children in England.
Last month, Schweitzer Engineering Laboratories (SEL) announced plans to expand into the medical device sector to produce a diagnostic for early autism spectrum disorder (ASD).
